Clinical Trial Update: Evaluation of HQ® Matrix Soft Tissue Mesh for the Treatment of Inguinal Hernia [NA]

View source ↗

Summary

Clinical trial update on evaluating HQ Matrix Soft Tissue Mesh for inguinal hernia; status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inguinal Hernia

Drugs mentioned

• HQ Matrix Soft Tissue Mesh

Snippet

Sponsor: Zhejiang Xingyue Biotechnology Co., Ltd. | Conditions: Inguinal Hernia | NA | Status: UNKNOWN